POSTPARTUM DEPRESSION
•
• 6 min read

Understanding the Use of Ubrelvy During Pregnancy, Breastfeeding, and Beyond

Gabriel Vince
Written by
Gabriel Vince
Understanding the Use of Ubrelvy During Pregnancy, Breastfeeding, and Beyond

Table of Contents

Overview of Ubrelvy: What You Need to Know

A serene and calming scene depicting a cozy, softly lit living room that emphasizes relaxation and health. In the foreground, a plush, light-colored sofa adorned with pastel throw pillows invites comfort. A tasteful coffee table, made of natural wood, holds a steaming cup of herbal tea, a small vase with fresh lavender, and a few migraine relief essentials like a cool cloth and a notepad. In the background, a large window lets in gentle sunlight, illuminating sheer white curtains that flutter slightly in the breeze. Lush green plants, such as a peace lily and a snake plant, are positioned on either side of the window, adding a touch of nature and tranquility. The walls are painted in soft, soothing colors like pale blue or mint green, enhancing the peaceful atmosphere. A framed abstract art piece, with swirls of calming colors, hangs above the sofa, suggesting movement and serenity. The overall ambiance conveys a sense of comfort and wellness, perfectly reflecting the theme of migraine management through a supportive and soothing home environment.

Ubrelvy (ubrogepant) is a medication specifically designed for the acute treatment of migraine. It functions as a calcitonin gene-related peptide (CGRP) receptor antagonist, which works by blocking the action of CGRP, a neurotransmitter involved in the pathophysiology of migraine headaches. This innovative treatment option has gained popularity due to its effectiveness in providing relief from migraine symptoms without the vasoconstrictive effects associated with traditional treatments, such as triptans (Sacco et al., 2021).

The medication is typically administered orally and is often well-tolerated, with a favorable safety profile. Ubrelvy has been shown to significantly reduce headache severity and associated symptoms, providing quick relief for many patients (Aurora et al., 2020). However, as with any medication, especially one used during sensitive periods such as pregnancy and breastfeeding, understanding its safety profile is crucial.

Safety Profile of Ubrelvy in Pregnant and Breastfeeding Women

The safety of medications taken during pregnancy is a significant concern for expectant mothers and healthcare providers. According to the American College of Obstetricians and Gynecologists (ACOG), about 80% of women report using at least one medication during pregnancy, making it vital to assess the potential risks and benefits (MedlinePlus, 2023).

While there is limited data specifically regarding the use of Ubrelvy in pregnant women, animal studies have not demonstrated teratogenic effects. However, the lack of comprehensive studies in human populations necessitates caution. It is essential to evaluate the individual circumstances of each woman, considering both the severity of her migraine condition and the potential risks associated with medication use (Maldonado et al., 2022).

For breastfeeding mothers, Ubrelvy is considered to have low levels in breast milk, and the risk of adverse effects in nursing infants appears to be minimal. Nevertheless, healthcare providers should engage in careful discussions with nursing mothers regarding the use of this medication, weighing the benefits of migraine relief against any potential risks (Miller et al., 2022).

Potential Risks and Benefits of Using Ubrelvy While Expecting

A serene and inviting scene unfolds in a softly lit room, showcasing a cozy nook designed for relaxation. In the foreground, a plush armchair draped with a light, textured throw sits beside a small wooden side table adorned with a steaming cup of herbal tea and a well-worn book. A delicate vase filled with fresh wildflowers adds a touch of color and vibrancy. The background features a large window with sheer curtains gently billowing, allowing warm, golden sunlight to filter through and illuminate the space. Lush greenery from outside peeks in, enhancing the tranquil atmosphere. On a nearby wall, a tastefully framed artwork depicting a peaceful landscape complements the natural theme. The room is finished with subtle decorative elements, such as soft cushions on the chair, a woven basket for magazines, and a cozy rug underfoot, creating an inviting ambiance perfect for moments of respite during a migraine attack. This photorealistic image captures the essence of comfort, calm, and the importance of self-care, resonating with the themes of managing migraines through relaxation and mindfulness.

When considering the use of Ubrelvy during pregnancy, the potential benefits must be weighed against the risks.

Benefits

  • Effective Relief: Ubrelvy provides rapid relief from acute migraine attacks, significantly improving quality of life and functionality during an often debilitating condition.
  • Non-Vasoconstrictive: Unlike triptans, Ubrelvy does not cause vasoconstriction, making it a safer option for women with vascular concerns (Burch et al., 2019).
  • Minimal Side Effects: Most patients experience tolerable side effects, which include nausea and somnolence but are generally not severe (Derry et al., 2020).

Risks

  • Lack of Human Data: The absence of extensive clinical trials in pregnant women raises concerns about potential unknown risks to fetal development (Charles & Pozo-Rosich, 2019).
  • Possible Impacts on Breastfeeding: Although limited data suggest low levels in breast milk, there is still uncertainty regarding its effects on breastfeeding infants (Keller et al., 2022).
  • Interactions with Other medications: Pregnant women may take various other medications, and the interaction with Ubrelvy could pose additional risks (Friedman et al., 2021).

Alternatives to Ubrelvy for Managing Migraines During Pregnancy

For pregnant women seeking alternatives to Ubrelvy, several options exist. Non-pharmacologic treatments are often first-line recommendations and include:

  1. Lifestyle Modifications: Regular hydration, adequate sleep, and balanced nutrition can help manage migraine symptoms.
  2. Cognitive-Behavioral Therapy (CBT): This therapy can assist in coping with the stress that may trigger migraines.
  3. Acupuncture: Some studies suggest acupuncture can reduce the frequency and intensity of migraine attacks in pregnant women (Lee et al., 2016).
  4. Physical Therapy: Gentle exercises and physical therapy may alleviate tension that contributes to migraines.

Pharmacologic alternatives may include:

  • Acetaminophen: Generally considered safe during pregnancy, it can help alleviate mild to moderate migraine pain.
  • NSAIDs: medications like ibuprofen may be used during the second trimester but should be avoided in the third (Gulati et al., 2020).
  • Triptans: Some studies suggest that certain triptans may be used cautiously during pregnancy, particularly if the benefits outweigh the risks (Miller et al., 2022).

Seeking Professional Guidance: Discussing Ubrelvy with Your Healthcare Provider

When contemplating the use of Ubrelvy during pregnancy or while breastfeeding, it is crucial to have an open dialogue with a healthcare provider. Pregnant women should discuss:

  • Pre-existing conditions: Any underlying health issues that may complicate treatment.
  • Migraine history: The frequency and severity of migraine attacks and past treatment responses.
  • Potential risks: Understanding the possible implications of using Ubrelvy or other medications during pregnancy.

Healthcare providers can offer personalized advice, recommend alternative treatments, and monitor both maternal and fetal health throughout the pregnancy.

FAQ Section

1. Can I take Ubrelvy during pregnancy?

While there is limited data on the safety of Ubrelvy during pregnancy, it is essential to consult your healthcare provider to assess the risks and benefits based on your individual situation.

2. Is Ubrelvy safe while breastfeeding?

Ubrelvy is considered to have low levels in breast milk, and the risk to nursing infants appears minimal, but it is still advisable to discuss this with your healthcare provider.

3. What are the alternatives to Ubrelvy for migraines during pregnancy?

Alternatives include lifestyle changes, cognitive-behavioral therapy, acupuncture, and medications like acetaminophen or some NSAIDs, depending on the trimester.

4. What should I do if I have a migraine while pregnant?

Consult your healthcare provider for guidance on safe treatment options tailored to your specific needs.

5. Can lifestyle changes help with migraines during pregnancy?

Yes, lifestyle modifications such as proper hydration, regular sleep, and stress management can help reduce the frequency and severity of migraine attacks.

References

  1. Aurora, S. K., et al. (2020). “Ubrogepant for the Treatment of Migraine.” New England Journal of Medicine, 383(23), 2205-2217. doi:10.1056/NEJMoa2000434
  2. Burch, R., et al. (2019). “A Review of the Efficacy and Safety of Ubrogepant in the Acute Treatment of Migraine.” Headache: The Journal of Head and Face Pain, 59(5), 710-718. doi:10.1111/head.13553
  3. Charles, A., & Pozo-Rosich, P. (2019). “Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy.” The Lancet Neurology, 18(1), 83-92. doi:10.1016/S1474-4422(18)30419-9
  4. Derry, C. J., et al. (2020). “Ubrogepant in Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.” Pain Physician, 23(1), E15-E22. doi:10.36076/ppj.2020/23/E15
  5. Friedman, M., et al. (2021). “Migraine Management in Pregnancy: A Review of Current Guidelines.” Journal of Midwifery & Women’s Health, 66(3), 290-298. doi:10.1111/jmwh.13165
  6. Gulati, A., et al. (2020). “The Safety of NSAIDs During Pregnancy: A Review.” Obstetrics & Gynecology, 135(1), 215-225. doi:10.1097/AOG.0000000000000327
  7. Keller, J. J., et al. (2022). “Breastfeeding and Its Impact on Migraine Management: A Review.” Journal of Clinical Neurology, 18(2), 250-257. doi:10.3988/jcn.2022.18.2.250
  8. Lee, J. H., et al. (2016). “Acupuncture for Migraine: A Systematic Review and Meta-Analysis.” The Clinical Journal of Pain, 32(2), 110-117. doi:10.1097/AJP.0000000000000460
  9. Maldonado, A., et al. (2022). “Pregnancy and Migraine: What We Know.” Current Neurology and Neuroscience Reports, 22(5), 1-9. doi:10.1007/s11910-022-01295-2
  10. MedlinePlus. (2023). “medication Use During Pregnancy
Gabriel Vince
Written by
Gabriel Vince

Gabriel has a Bachelor’s degree in Psychology from the University of Washington. He writes about mental health and wellness for various online platforms. In his free time, Gabriel enjoys reading, meditating, and hiking in the mountains.

Related

See all POSTPARTUM DEPRESSION
POSTPARTUM DEPRESSION
•

Unlocking the Power of Zurzuvae: Optimal Dosage, Forms, and Essential Guidelines for Managing Postpartum Depression

Postpartum depression (PPD) is a significant mental health issue affecting about 1 in 7 new mothers, characterized by symptoms such as persistent sadness, anxiety, and feelings of inadequacy. Hormonal changes post-childbirth, along with factors like …

Emily Fawn
Written by
Emily Fawn
POSTPARTUM DEPRESSION
•

Understanding Zurzuvae: Interactions with Other Drugs and Alcohol

Zuranolone, known as Zurzuvae, is a groundbreaking FDA-approved oral medication for postpartum depression (PPD) that can alleviate symptoms in as little as three days, with a typical treatment duration of two weeks. Unlike traditional antidepressants …

Linwood Mark
Written by
Linwood Mark
POSTPARTUM DEPRESSION
•

Understanding the Spectrum of Maternal Mood Disorders: Baby Blues and Postpartum Depression

The article distinguishes between Baby Blues and Postpartum Depression (PPD), two conditions that affect new mothers. Baby Blues are temporary, mild mood swings and emotional distress occurring within the first two weeks postpartum, while PPD is a …

Wendell Braidy
Written by
Wendell Braidy
POSTPARTUM DEPRESSION
•

Understanding Topamax: Effects on Pregnancy, Breastfeeding, and Beyond

The article discusses the use of Topamax (topiramate) during pregnancy, highlighting its classification as a pregnancy category D drug by the FDA, which indicates potential risks to the developing fetus. Research has shown that Topamax can increase …

Niles Winthrop
Written by
Niles Winthrop